Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

663

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

May 12, 2027

Study Completion Date

May 12, 2027

Conditions
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Interventions
COMBINATION_PRODUCT

Toripalimab combined with cisplatin and paclitaxel

Specified doses on specified days.

COMBINATION_PRODUCT

Placebo combined with cisplatin and paclitaxel

Specified doses on specified days.

Trial Locations (48)

121001

The first affiliated hospital of jinzhou medical university, Jinzhou

130031

China-Japan Union hosptial of Jilin university, Changchun

230001

Anhui provincial hospital, Hefei

315010

Hwa Mei Hospital,University of Chinese Academy of sciences, Ningbo

317000

Taizhou hospital of zhejiang province, Taizhou

410013

Hunan provincial cancer hospital, Changsha

450003

Henan provincial pepples hospital, Zhengzhou

450052

The first affilated hospital of zhengzhou university, Zhengzhou

518040

Shenzhen people's hosptial, Shenzhen

Unknown

The Firest Affiliated Hospital of bengbu Medical College, Bengbu

The Second Hospital of anhui Medical University, Hefei

Jiangmen central Hospital, Jiangmen

Anyang Cancer Hospital, Anyang

The First Affiliated Hospital of xinxiang Medical University, Xinxiang

Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi

Beijing Cancer Hospital, Beijing

Peking University Third Hospital, Beijing

The General Hospital of People's Liberation Army, Beijing

Heping Hospital Affiliated to changzhi Medical College, Changzhi

Sichuan Cancer Hospital & Institute, Chengdu

Fujian Cancer Hospital, Fuzhou

3201 Hospital, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

The First Affiliated Hospital, Zhejiang University School of Medicine, Hanzhou

harbin medical university Cancer Hospital, Harbin

Anhui Provincial Cancer Hospital, Hefei

Huai'an First People's Hospital, Huai'an

The Affiliated Hospital of jining Medical University, Jining

The First Affiliated Hospital of nanchang University, Nanchang

Jiangsu Cancer Hospital, Nanjing

The Affiliated Hospital of Qingdao University, Qingdao

Zhongshan Hospital Fudan University, Shanghai

Shantou University Cancer Hospital, Shantou

Liaoning cancer hospital& Institute, Shenyang

Shengjing Hospital of China Medical University, Shenyang

The first Hospital of china Medical University, Shenyang

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Hubei Cancer Hospital, Wuhan

Renmin Hospital of Wuhan University, Wuhan

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

The First Affiliated Hospital of Xiamen University, Xiamen

Zhongshan Hospital Affiliated to Xiamen University, Xiamen

Xinyang central Hospital, Xinyang

The Affiliated Hospital of xuzhou Medical University, Xuzhou

Yantai yuhuangding Hospital, Yantai

Henan Cancer Hospital, Zhengzhou

050019

The fourth hospital of hebei medical university, Shijiazhuang

030013

Shanxi provincial cancer hosptial, Taiyuan

All Listed Sponsors
lead

Shanghai Junshi Bioscience Co., Ltd.

OTHER